Personalized Search
Displaying 341 - 360 of 1048
Dr. Sioban Keel discusses inherited disorders, genetic testing, how these disorders are diagnosed, and their impact on treatment decisions and care.
Webinar last updated
.
Dr. Sioban Keel discusses the signs and symptoms of
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most…
,…
Webinar last updated
.
Dr. Anna Halpern discusses the signs and symptoms of
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most…
,…
Webinar last updated
.
Dr. Bart Scott provides an overview of
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most…
,…
Webinar last updated
.
In this webinar, Dr. Lacey Williams discusses the diagnosis of High Risk MDS and treatment options available to patients.
Webinar last updated
.
In this webinar, Dr. Akriti Jain discusses research most relevant to patients reported over the past year on the biology and treatment of Lower Risk MDS. These studies were presented at the American Society of Hematology (ASH) 2025 meeting, and their findings will be explained along with the potential impact of this research on understanding and treating Lower Risk MDS. This is an advanced…
Webinar last updated
.
Dr. Anna Halpern discusses how leukemic transformation is identified, what it means for prognosis, and how patients and their healthcare teams can navigate treatment decisions.
Webinar last updated
.
Tregzi is the first regulatory T (Treg) cell-based immunotherapy for improving chronic
graft-versus-host disease (GVHD)
graft-versus-host disease (GVHD):
Also called GVHD, it is a common complication of bone marrow/stem cell transplantation. It is caused when the donor's immune cells, now in the patient, begin to see the the patient's body as foreign and mount an immune response. GVHD…
Drug last updated
.
Omisirge is the first cellular therapy approved to treat patients with severe
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell…
Downloadable last updated
.
Omisirge is the first cellular therapy approved to treat patients with severe
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell…
Drug last updated
.
In this webinar, Dr. Akriti Jain will explains the latest research presented the American Society of Hematology meeting on MDS and secondary AML. This is an advanced presentation.
Webinar last updated
.
Alemtuzumab is a drug used in the treatment of
chronic lymphocytic leukemia (CLL)
chronic lymphocytic leukemia (CLL):
(CRAW-nik lim-foe-SIGH-tick loo-KEE-mee-uh) Chronic lymphocytic leukemia is a type of blood, lymph node and bone marrow cancer in which too many abnormal white blood cells called lymphocytes accumulate in your body.
, cutaneous T-cell lymphoma (CTCL) and…
Drug last updated
.
Christy was a nurse in pediatrics for over 12 years. She was training to have a key role in the neonatal unit. But her plans were interrupted in May, 2026.Christy and her physician husband were enjoying life with their two young children after a recent relocation. One day in early May, her husband noticed unusual bruising on her legs. She was fatigued, but brushed it off as a…
Patient Chronicle last updated
.
In this recording, Dr. Jeremy Meier discusses the journey of a transplant (before, during and after) and potential management of GVHD.
Webinar last updated
.
The primary goal of this RENEW study is to find out how well elritercept works in lowering the need for
red blood cell
red blood cell:
The most numerous type of blood cell in healthy people. Red blood cells contain hemoglobin, a protein that picks up oxygen in the lungs and brings it to cells in all parts of the body. Also called erythrocyte, RBC.
(RBC) transfusions. Other aims…
Clinical Trial last updated
.
Dr. Nikolai Podoltsev presents this session for
Aplastic Anemia
Aplastic Anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most…
non-…
Webinar last updated
.
Dr. Mina Xu discusses the steps involved in developing an accurate diagnosis for
bone marrow failure
bone marrow failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin…
Webinar last updated
.
Lisa Barbarotta describes techniques to help manage low blood counts in this session.
Webinar last updated
.
Dr. Nicolai Podoltsev describes options available for patients with PNH who could choose non-transplant treatments.
Webinar last updated
.